Community members were given the opportunity to voice their opinions Monday evening regarding the future of Dowagiac Union ...

CC Sabathia will have a New York Yankees logo on the cap of his Hall of Fame plaque and Bill Wagner will have the symbol of ...

The Oriskany Central School District hosted its Skyhawks logo reveal and celebration Friday, Feb. 7 in the Keith Davis ...

A committee of administration members and coaches from Litchfield and Dassel-Cokato schools have chosen a logo aimed at connecting all their co-op sports teams. But the logo will not change what ...

American depositary receipts (ADRs) of Novo Nordisk (NVO) jumped over 4% in pre-market trading this morning after reporting a healthy sales ...

The results of the first head-to-head trial of Lilly's dual GLP-1/GIP agonist Zepbound (tirzepatide) and Novo Nordisk's GLP-1 agonist Wegovy (semaglutide) have shown experimentally what has been ...

In December and January, the US Food and Drug Administration (FDA) approved new therapies for lung cancer, atopic dermatitis, obstructive sleep apnea (OSA), and cystic fibrosis. The FDA also added a ...

It is a miracle drug." GLP-1 agonist drugs, like Ozempic, Wegovy, Mounjaro and Zepbound, can help with weight loss by mimicking at least one hormone produced by the gut to signal fullness ...

Zepbound (tirzepatide) is only available on prescription for people with obesity, or those with overweight. Learn how to get Zepbound online, in-person, and through the drug’s manufacturer, Eli ...

Sangeetha Nadarajah reports Amid the rising popularity of glucagon-like peptide-1 (GLP-1) receptor agonists for weight loss such as semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound), ...

Eli Lilly and Co. reported that its FDA-approved weight-loss drug Zepbound (tirzepatide) outperformed Novo Nordisk A/S’s Wegovy (semaglutide) in the phase IIIb Surmount-5 trial.